Featured image for “NAL Shares Behind-the-Scenes Look at Development of NAL-NL3”
Dec. 03, 2025

NAL Shares Behind-the-Scenes Look at Development of NAL-NL3

HHTM
The National Acoustic Laboratories (NAL) has released a new video, The Making of the NAL-NL3 Fitting System, providing a behind-the-scenes look at how its latest hearing aid fitting system was created. NAL-NL3, launched on September 22, 2025, succeeds NAL-NL2 nearly 15 years after its release and is designed to reflect evolving clinical needs, advances in hearing technology, and changing expectations
Featured image for “GN Opens New North American Headquarters in Minnesota”
Dec. 03, 2025

GN Opens New North American Headquarters in Minnesota

HHTM
SHAKOPEE, MINNESOTA – GN today celebrated the grand opening of its new North American headquarters in Shakopee, Minnesota. The 218,437-square-foot facility will serve as a regional operational center for all GN brands and as the U.S. headquarters for ReSound and Jabra Enhance hearing aids. Representatives from the City of Shakopee, the Shakopee Chamber of Commerce, Minnesota elected officials, former employees,
Featured image for “PEDMARK® Study in Japan Shows Significant Reduction in Cisplatin-Related Hearing Loss in Pediatric Patients”
Dec. 02, 2025

PEDMARK® Study in Japan Shows Significant Reduction in Cisplatin-Related Hearing Loss in Pediatric Patients

HHTM
RESEARCH TRIANGLE PARK, N.C. — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced positive topline results from the investigator-initiated Phase 2/3 STS-J01 clinical trial evaluating PEDMARK® (sodium thiosulfate injection) for reducing cisplatin-induced ototoxicity in pediatric and adolescent and young adult (AYA) patients with non-metastatic solid tumors in Japan. PEDMARK® is the first and only U.S. Food
Featured image for “The Hearing Matters Podcast Launches Thought Leader Coalition to Support the Future of Hearing Healthcare”
Dec. 02, 2025

The Hearing Matters Podcast Launches Thought Leader Coalition to Support the Future of Hearing Healthcare

HHTM
CHARLESTON, SOUTH CAROLINA — The Hearing Matters Podcast announced the launch of its new Thought Leader Coalition, bringing together three established figures in hearing healthcare: Dr. Gyl Kasewurm, Dr. Jasen A. Ruiz, and Madison Levine, B.C.-HIS. The initiative is designed to expand the podcast’s role as a resource for clinical education, patient engagement, and hearing-health innovation. The coalition will produce
Featured image for “Life With a Fully Implanted Cochlear Implant: Michael Seufer Shares His Experience”
Dec. 02, 2025

Life With a Fully Implanted Cochlear Implant: Michael Seufer Shares His Experience

HHTM
A fully implantable cochlear implant isn’t just a technical milestone—it’s a fundamentally different way of living with hearing loss. In a candid conversation, Gael Hannan speaks with Michael Seufer, one of the first recipients of the Envoy Medical Acclaim, an investigational fully implanted cochlear implant that eliminates external hardware. Michael shares how his hearing loss, first identified in childhood, shaped
Featured image for “Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 in Meniere’s Disease”
Dec. 01, 2025

Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 in Meniere’s Disease

HHTM
SEATTLE, WASHINGTON — Sound Pharmaceuticals (SPI) announced that the U.S. Food and Drug Administration (FDA) has granted its investigational drug, SPI-1005, Breakthrough Therapy Designation (BTD) for the treatment of hearing loss associated with Meniere’s disease (MD). MD is a complex inner ear disorder involving low-to-mid frequency hearing loss, tinnitus, vertigo, and dizziness. This marks the first BTD granted for a
Featured image for “Cilcare Wins First Prize at the 2025 Enterprise Europe Network Awards”
Dec. 01, 2025

Cilcare Wins First Prize at the 2025 Enterprise Europe Network Awards

HHTM
AALBORG, DENMARK – Cilcare has been awarded the First Prize at the 2025 Enterprise Europe Network (EEN) Awards, recognizing the company’s successful use of EEN support to advance its work in hearing loss research. CEO and co-founder Celia Belline accepted the award in Aalborg, where three finalists competed for the distinction. Millions of people worldwide live with hearing loss, yet treatment
Featured image for “Expanding the Hearing Health Care Team”
Nov. 30, 2025

Expanding the Hearing Health Care Team

HHTM
by Terry Mactaggart, President and CEO, Summus Hearing If the hearing health problem is to be confronted effectively, we need to weave hearing care into more corners of health and community life. Beyond family physicians (who are typically unengaged and need to be incented), the current array includes the following: Licensed Hearing Care Professionals Approximately 27,000 hearing health providers are
Featured image for “IHS Highlights Ways to Make Holiday Gatherings More Hearing-Friendly”
Nov. 26, 2025

IHS Highlights Ways to Make Holiday Gatherings More Hearing-Friendly

HHTM
FARMINGTON HILLS, MICHIGAN — With year-end holiday gatherings approaching, the International Hearing Society (IHS) is encouraging individuals who may be experiencing hearing loss to take steps to address their hearing so they can participate more fully in celebrations with family, friends, and colleagues. “The holidays can be overwhelming for individuals with hearing loss because of background noise that magnifies their
Featured image for “Exploring the Lexie H1 Hearing Buds: LXE’s Entry Into Earbud-Style OTC Hearing Aids”
Nov. 25, 2025

Exploring the Lexie H1 Hearing Buds: LXE’s Entry Into Earbud-Style OTC Hearing Aids

HHTM
A growing number of people are exploring hearing help earlier, and LXE Hearing believes there is a place for devices that bridge the gap between everyday earbuds and traditional hearing aids. In a detailed discussion, LXE Chief Commercial Officer Brian Maguire explains how the newly formed company—created from the merger of Lexie, hearX, and Eargo—is blending strong hardware engineering with